Recently, the genetic landscape of CMML has been increasingly elucidated and mutations in TET2 (~60%), SRSF2 (~50%), ASXL1 (~40%), and SETBP1 (~15%) are common but not specific for CMML [10,11]. Here, SRSF2 is linked to chronic myelomonocytic leukemia.